Nano-enhanced tobramycin treats severe lung infections with only 2 doses
Phys.org - 13-May-2021Antibiotic's efficacy improved by 100,000 times in treating cystic fibrosis - currently in preclinical stage
Join the club for FREE to access the whole archive and other member benefits.
Pharmacist, PhD student at the University of South Australia
Chelsea Thorn is a PhD student at the University of South Australia and is also a visiting PhD researcher at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). She holds a Bachelor of Pharmacy (Hons) from the University of South Australia and is currently an Australian registered Pharmacist. Her research focus is based around improving the delivery of antimicrobial bio-macromolecules to treat biofilm-related infections.
Visit website: https://unisa-au.academia.edu/ChelseaThorn
See also: University of South Australia (UniSA) - Public Research university.
Details last updated 23-May-2021
Antibiotic's efficacy improved by 100,000 times in treating cystic fibrosis - currently in preclinical stage